Do Analysts Think Bausch Health Companies Inc (BHC) Is Still Worth Buying In 2024?

Bausch Health Companies Inc (NYSE:BHC) does about 2.81M shares in volume on a normal day but saw 3176974 shares change hands in Monday trading. The company now has a market cap of 3.15B USD. Its current market price is $8.63, marking a decrease of -1.48% compared to the previous close of $8.76. The 52 week high reached by this stock is $11.46 whilst the lowest price level in 52 weeks is $5.57.

Bausch Health Companies Inc (BHC) has a 20-day trading average at $9.67 and the current price is -24.69% off the 52-week high compared with 54.93% distance from its 52-week low. The 50-day simple moving average of the closing price is $9.18 and its 200-day simple moving average is $8.28. If we look at the stock’s price movements over the week, volatility stands at 7.84%, which decreases to 5.40% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 36.22 to suggest the stock is neutral.

The consensus objective for the share price is $10.33, suggesting that the stock has a potential upside of 16.46% over the period.

The company shares received a number of brokerage firm price updates over the past month, with the latest being on September 20, 2023 when Jefferies upgraded the stock to “Buy” and issued a price target of between $9 and $16.

Bausch Health Companies Inc (BHC) stock is down -10.94% over the week and -5.06% over the past month. Its price is 7.61% year-to-date and 14.46% over the past year.

To reach the target analysts have set, the stock logically needs to grow 16.46 percent from here.

The company has a return on investment of -2.81%. The forward price to earnings ratio is 2.11. The beta has a value of 0.89. Price to sales ratio is 0.36.